Tejas Savant
Stock Analyst at Morgan Stanley
(0)
# 4416
Out of 5,332 analysts
294
Total ratings
31.06%
Success rate
-14.36%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HOLX Hologic | Maintains: Equal-Weight | 77 65 | 53.16 | 22.27% | 9 | May 5, 2025 | |
CYRX CryoPort | Maintains: Equal-Weight | 8 7 | 5.57 | 25.67% | 2 | May 5, 2025 | |
ADPT Adaptive Biotechnolo... | Maintains: Equal-Weight | 7 9 | 8.82 | 2.04% | 12 | May 5, 2025 | |
NEO NeoGenomics | Maintains: Equal-Weight | 17 10 | 7.71 | 29.7% | 13 | May 1, 2025 | |
AVTR Avantor | Downgrades: Equal-Weight | 25 15 | 12 | 25% | 17 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | 2.04 | 145.1% | 13 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 20 | 32.16 | -37.81% | 2 | Mar 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 50 60 | 52.25 | 14.83% | 2 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 176 185 | 155.48 | 18.99% | 13 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 26 | 8.12 | 220.2% | 13 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 245 250 | 146.21 | 70.99% | 11 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 150 136 | 74.61 | 82.28% | 7 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 647 678 | 407.79 | 66.26% | 14 | Jan 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 24 23 | 21.23 | 8.34% | 1 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 26 28 | 30.54 | -8.32% | 12 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 32 21 | 7.29 | 188.07% | 2 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 4 2 | 1.11 | 80.18% | 11 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 4 3 | 1.14 | 163.16% | 10 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 80 40 | 6.45 | 520.16% | 2 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 26 26 | n/a | n/a | 12 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 8 7 | 3.69 | 89.7% | 8 | Nov 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 8 | n/a | n/a | 11 | Oct 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 52 55 | n/a | n/a | 11 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 | n/a | n/a | 1 | Aug 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 6 6 | 0.67 | 795.52% | 3 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 10 | 3 | 233.33% | 8 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 3 | 2.29 | 20.09% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 5 | 4.02 | 24.38% | 12 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 10 | 1.9 | 426.32% | 10 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 73 | 41.98 | 73.89% | 9 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 2 | n/a | n/a | 5 | Jan 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 10 8 | n/a | n/a | 4 | Aug 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 5 | n/a | n/a | 8 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 350 250 | 115.23 | 116.96% | 1 | Aug 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | 0.45 | 1011.11% | 5 | May 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 19 | n/a | n/a | 3 | May 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 17 | n/a | n/a | 8 | May 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 21 20 | n/a | n/a | 2 | Mar 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 35 65 | n/a | n/a | 1 | Feb 22, 2021 |